Company / Cost of Revenue
Elevance Health Cost of Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$21.2B
FY2025
5-year range
$2.0B / $21.2B
FY2021-FY2025
Trend
+7.2%
vs FY2024
Sector context
#7 of 113
Health Care
What the data says
Among 113 Health Care companies, Elevance Health is in the bottom 6% for cost of revenue. Cost of Revenue has fluctuated over the past 9 years, ranging from $0 in FY2018 to $21.2B in FY2025.
Based on SEC 10-K filings.
$21.2B in FY2025 with a 5-year CAGR of +18.8%. Top quartile in the Health Care sector.
Increased from $10.9B to $21.2B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +17.6%
- 5-Year CAGR
- +18.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 113This company $21.2B Sector average $11.3B
▼
+87.5% above sector average
Key checks
Key Insights
- 5-year CAGR of +18.8%, indicating consistent growth.
- In FY2025, cost of revenue increased 7.2% year-over-year.
- Ranks #7 out of 113 companies in the Health Care sector.
- Lowest cost of revenue in the period was in FY2018.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.2B | +7.2% |
| FY2024 | $19.8B | +81.3% |
| FY2023 | $10.9B | -16.4% |
| FY2022 | $13.0B | +554.4% |
| FY2021 | $2.0B | -77.8% |
| FY2020 | $9.0B | +349.4% |
| FY2019 | $2.0B | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026